Delivery Order SPE2DR25D1100-SPE2DR26FDF8N

<p>The Defense Logistics Agency issued a $3,836 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for NUBEQA 300 mg tablets (120 tablets) under the company's existing indefinite delivery contract with DLA Troop Support Medical.</p> <p>The order is firm fixed price with a ceiling value of $3,836 and ultimate completion by February 27, 2026. Place of performance is Conshohocken, PA.</p>

The Defense Logistics Agency awarded a $3,836.00 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Nubeqa 300 mg on December 11, 2025, with an ultimate completion date of January 5, 2026. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Nubeqa 300 mg tablets (120-count packages) with a ceiling value of $8,670.74. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award to the prime contractor. The order is scheduled for ultimate completion by January 27, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....

The Defense Logistics Agency awarded a $3,836.00 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Nubeqa 300 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 20, 2026. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...

The Defense Logistics Agency issued a $7,672 delivery order to AmerSourceBergen Drug Corp on February 5, 2026, for 120-count tablets of Nubeqa 300 mg, with a completion date of February 27, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside designation. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a comprehensive Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through...

The Defense Logistics Agency awarded a $3,836.00 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Nubeqa 300 mg tablets (120-count units), with an ultimate completion date of January 6, 2026. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office location in...

The Defense Logistics Agency awarded a delivery order valued at $3,836.00 to AmerisourceBergen Drug Corp for the supply of Nubeqa 300 mg tablets (120-count units) on December 29, 2025, with a completion date of January 21, 2026. This firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded...

<p>The Defense Logistics Agency issued a $3,836 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Nubeqa 300 mg tablets (120-count supply).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and ultimate completion date of March 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $3,836.00 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for NUBEQA 300 mg tablets (120 count). Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026.</p>

The Defense Logistics Agency (DLA) awarded a $3,836.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Nubeqa 300 mg, with an ultimate completion date of February 4, 2026. This non-set-aside award was issued on January 13, 2026, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical...